BAYER AG S/ADR - BAYRY STOCK NEWS

Bayer has appointed Ben Kampelman, previously Director of Strategic Communications for Crop Science North America, as the new Vice President of Communications for the Crop Science division in North America. In this role, Kampelman will oversee all corporate communications activities, focusing on corporate reputation and media relations. With over 20 years of experience at Bayer and its predecessor Monsanto, he brings extensive industry knowledge. This leadership change is expected to enhance Bayer's communication strategies in North America, supporting its vision of Health for All, Hunger for None. Kampelman assumed his role in November 2022.

ONIT Sciences announced that Eric Mathur, a distinguished plant geneticist and molecular biologist, has been appointed as the company’s Chief Science Officer. With over 40 years of experience, Mathur has expertise in genome sciences, molecular biology, and agricultural biotechnology. He aims to enhance ONIT's research and development efforts and has already initiated field trials to optimize the company’s products for various applications, including cattle ranching. ONIT Sciences, founded in 2018, focuses on increasing crop yield and plant health through organic technologies.

PRT Growing Services Ltd., a leader in container-grown forest seedlings, has appointed Collin Phillip as Chief Commercial Officer and Marlene Higgins as Chief People Officer. These strategic hires are aimed at enhancing PRT’s position for future growth. Phillip brings a strong background in sales and supply chain from companies like Corteva Agriscience and The Monsanto Company, while Higgins has extensive HR experience from Structurlam. Together, they are expected to drive success in expanding PRT’s services and nurturing its workforce.

Bactobio Ltd, a London-based biotechnology firm, has successfully closed an oversubscribed £6 million bridge financing round led by Bridford Group. The round included notable supporters such as former executives from Novozymes and Monsanto, alongside new investors from fintech companies. The funds will enhance Bactobio's discovery pipeline and further its work in developing safer antimicrobial solutions from unexplored microbes. CEO Dr. Daniel Hansen expressed pride in the company's progress and continued support from high-caliber investors.

Pivot Bio, a leader in nitrogen innovation, announced significant management changes to support its growth. Roger Underwood joins as independent director and Chairperson, bringing extensive ag tech experience. Lisa Safarian is promoted to President & COO, overseeing operations after leading Bayer's $9.5 billion North American crop science business. Evan Wittenberg is appointed as Chief People Officer, and Ernie Sanders is promoted to Senior VP of Product Innovation, focusing on expanding product offerings. These changes aim to enhance Pivot Bio's commitment to providing farmers with reliable nitrogen solutions.

PPG has announced the appointment of Tim Knavish as the new President and CEO effective January 1, 2023. Knavish, who has served as COO since March, will succeed Michael McGarry, who transitions to Executive Chairman after leading the company since September 2015. The change is expected to enhance PPG's growth strategy amid current economic challenges. Knavish brings extensive experience from various leadership roles at PPG, which operates globally and reported $16.8 billion in net sales for 2021.

Bayer has appointed William Dodero as the new U.S. General Counsel effective January 1, 2023. He succeeds Scott Partridge, who is leaving to focus on dispute resolution. Dodero brings 20 years of experience with Bayer and has successfully led the company's legal strategies in various areas, including the Roundup litigation. He will oversee compliance, corporate law, and other legal functions. Patrick Lockwood-Taylor, President of Bayer U.S., expressed enthusiasm about Dodero's leadership amid growing challenges in food security and healthcare.

Prime Medicine has appointed Wendy Chung, Kaye Foster, and Michael A. Kelly to its board of directors. These new members bring extensive experience in research and development, financial management, and human resources, enhancing the company’s leadership. CEO Keith Gottesdiener emphasized the importance of a strong team to advance their novel Prime Editing technology, which aims to provide one-time curative genetic therapies for a wide range of diseases. This appointment is expected to support the company’s goal of delivering potentially life-changing treatments.

The Fears Nachawati law firm is urging a federal judge to reject a proposed settlement between Bayer (OTCMKTS: BAYZF, BAYRY) and consumers seeking reimbursement for Roundup. They allege that the settlement could limit cancer victims' ability to seek justice. Representing over 4,000 cancer victims, the firm raises concerns about collusion due to generous legal fees and ambiguous language that may protect Monsanto from damages. Previous attempts at a similar settlement were blocked by the JPML. Notably, several trials have found that Roundup exposure causes cancer, leading to multimillion-dollar verdicts.